Quick Answer
Journey Medical Corp reported R&D Expense of $480.0 thousand for fiscal year 2025.
Journey Medical Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $480.0K | -95.1% |
| 2024 | $9.86M | +30.7% |
| 2023 | $7.54M | -31.1% |
| 2022 | $10.94M | +299.5% |
| 2021 | $2.74M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $287.0K | -65.9% | +635.9% |
| March 31, 2025 | $39.0K | -99.5% | -95.4% |
| September 30, 2024 | $842.0K | -62.2% | -7.8% |
| June 30, 2024 | $913.0K | -48.5% | -88.4% |
| March 31, 2024 | $7.88M | +287.8% | +253.7% |
| September 30, 2023 | $2.23M | -20.7% | +25.6% |
| June 30, 2023 | $1.77M | -32.0% | -12.7% |
| March 31, 2023 | $2.03M | +60.6% | -27.7% |
- Journey Medical Corp showed a decrease of -95.1% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2025 period, Journey Medical Corp’s r&d expense has declined by 82.5% (from $2.74 million to $480.0 thousand).
- The most recent figure is from Journey Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: